SK17082002A3 - Spôsob prípravy (2R,2-alfa-R,3a)-2-[1-(3,5- bis(trifluórmetyl)fenyl)etoxy]-3-(4-fluórfenyl)-1,4-oxazínu - Google Patents

Spôsob prípravy (2R,2-alfa-R,3a)-2-[1-(3,5- bis(trifluórmetyl)fenyl)etoxy]-3-(4-fluórfenyl)-1,4-oxazínu Download PDF

Info

Publication number
SK17082002A3
SK17082002A3 SK1708-2002A SK17082002A SK17082002A3 SK 17082002 A3 SK17082002 A3 SK 17082002A3 SK 17082002 A SK17082002 A SK 17082002A SK 17082002 A3 SK17082002 A3 SK 17082002A3
Authority
SK
Slovakia
Prior art keywords
trifluoromethyl
bis
phenyl
fluorophenyl
ethoxy
Prior art date
Application number
SK1708-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Karel M. Jos Brands
Fuh-Rong Tsay
Karen M. Conrad
Matthew M. Zhao
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of SK17082002A3 publication Critical patent/SK17082002A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SK1708-2002A 2000-06-08 2001-06-04 Spôsob prípravy (2R,2-alfa-R,3a)-2-[1-(3,5- bis(trifluórmetyl)fenyl)etoxy]-3-(4-fluórfenyl)-1,4-oxazínu SK17082002A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21020300P 2000-06-08 2000-06-08
PCT/US2001/018042 WO2001094324A1 (en) 2000-06-08 2001-06-04 Process for the synthesis of (2r, 2-alpha-r, 3a)-2-[1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-1,4-oxazine

Publications (1)

Publication Number Publication Date
SK17082002A3 true SK17082002A3 (sk) 2003-04-01

Family

ID=22781976

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1708-2002A SK17082002A3 (sk) 2000-06-08 2001-06-04 Spôsob prípravy (2R,2-alfa-R,3a)-2-[1-(3,5- bis(trifluórmetyl)fenyl)etoxy]-3-(4-fluórfenyl)-1,4-oxazínu

Country Status (19)

Country Link
US (1) US6600040B2 (es)
EP (1) EP1292584A1 (es)
JP (1) JP2003535852A (es)
KR (1) KR20030007887A (es)
CN (1) CN1182125C (es)
AR (1) AR030284A1 (es)
AU (1) AU2001268170A1 (es)
BR (1) BR0111472A (es)
CA (1) CA2410404A1 (es)
CZ (1) CZ20024013A3 (es)
EA (1) EA004743B1 (es)
HR (1) HRP20020973A2 (es)
HU (1) HUP0400491A2 (es)
IL (1) IL152793A0 (es)
MX (1) MXPA02012101A (es)
NZ (1) NZ523389A (es)
PL (1) PL359137A1 (es)
SK (1) SK17082002A3 (es)
WO (1) WO2001094324A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001094323A1 (en) * 2000-06-08 2001-12-13 Merck & Co., Inc. Process for the synthesis of (2r, 2-alpha-r)-4-benzyl-2-[1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-1,4-oxazin-3-one
FR2876101B1 (fr) 2004-10-05 2007-03-02 Sidem Pharma Sa Sa Procede de preparation enantioselective de derives de sulfoxydes
WO2012146692A1 (en) 2011-04-29 2012-11-01 Sandoz Ag Novel intermediates for the preparation of highly pure aprepitant or fosaprepitant
CN103012305B (zh) * 2011-09-23 2016-08-17 江苏豪森药业集团有限公司 一种福沙匹坦中间体的制备方法
CN103030668B (zh) * 2011-10-09 2016-06-15 江苏豪森药业集团有限公司 一种制备福沙匹坦二甲葡胺的方法
CZ304770B6 (cs) 2012-03-13 2014-10-08 Zentiva, K.S. Způsob výroby 3-(((2R,3S)-2-((R)-1-(3,5-bis(trifluormethyl)fenyl)ethoxy)-3-(4-fluorfenyl)morfolino)methyl)-1H-1,2,4-triazol-5(4H)-onu (Aprepitantu) v polymorfní formě II
CN102675240B (zh) * 2012-04-13 2015-01-14 浙江海正药业股份有限公司 4-取代基-2-羟基吗啉-3-酮及其制备方法
CN104327009B (zh) * 2014-09-24 2016-07-20 山东省生物医药科学院 一种阿瑞匹坦关键中间体的精制方法
CN104447607B (zh) * 2014-12-12 2017-02-22 瑞阳制药有限公司 阿瑞匹坦中间体的制备方法
CN104557760A (zh) * 2015-01-28 2015-04-29 武汉励合生物医药科技有限公司 阿瑞吡坦中间体的制备方法
CN106397349A (zh) * 2016-08-31 2017-02-15 安徽省润生医药股份有限公司 一种阿瑞吡坦中间体及其制备方法
CN109516964B (zh) * 2017-09-19 2022-05-31 鲁南制药集团股份有限公司 一种阿瑞匹坦中间体的制备方法
CN109694360A (zh) * 2018-12-28 2019-04-30 凯瑞斯德生化(苏州)有限公司 一种阿瑞匹坦中间体的制备方法
CN110746371B (zh) * 2019-11-20 2022-07-15 山东鲁抗医药股份有限公司 制备阿瑞匹坦的中间体及其制备方法与应用
CN114235340B (zh) * 2020-06-09 2023-11-10 重庆交通大学 河道泡漩结构跟踪方法及通航预警方法
CN111829749A (zh) * 2020-07-27 2020-10-27 中国空气动力研究与发展中心高速空气动力研究所 一种用于风洞超声速流校大行程单点移测装置及布线方法
CN113582982B (zh) * 2021-06-15 2023-06-16 山东罗欣药业集团股份有限公司 一种nk1受体拮抗剂的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5719147A (en) * 1992-06-29 1998-02-17 Merck & Co., Inc. Morpholine and thiomorpholine tachykinin receptor antagonists
IL111960A (en) * 1993-12-17 1999-12-22 Merck & Co Inc Morpholines and thiomorpholines their preparation and pharmaceutical compositions containing them
BR9408442A (pt) 1993-12-29 1997-08-05 Merck Sharp & Dohme Composto composição farmacêutica processos para tratamento ou prevenção de distúrbios fisiológicos associados com um excesso de taquiquininas e para a preparação do composto e de uso do composto
ZA985765B (en) 1997-07-02 1999-08-04 Merck & Co Inc Polymorphic form of a tachykinin receptor antagonist.
GB9813025D0 (en) 1998-06-16 1998-08-12 Merck Sharp & Dohme Chemical synthesis
CA2342213A1 (en) * 1998-09-11 2000-03-23 Merck & Co., Inc. Process for the synthesis of n-benzyl-3-(4-fluorophenyl)-1,4-oxazin-2-one
JP2002528546A (ja) 1998-10-30 2002-09-03 メルク エンド カムパニー インコーポレーテッド 2−(r)−(1−(r)−(3,5−ビス(トリフルオロメチル)フェニル)エトキシ−4−((5−ジメチルアミノメチル)−1,2,3−トリアゾル−4−イル)メチル)−3−(s)−(4−フルオロフェニル)モルホリン化合物の製造方法
AU1230000A (en) 1998-10-30 2000-05-22 Merck & Co., Inc. Linear process for the preparation of a morpholine compound
ES2214060T3 (es) * 1998-12-29 2004-09-01 PHARMACIA & UPJOHN COMPANY Procedimiento para la preparacion de arileteres.

Also Published As

Publication number Publication date
PL359137A1 (en) 2004-08-23
AU2001268170A1 (en) 2001-12-17
CN1436178A (zh) 2003-08-13
EA200300002A1 (ru) 2003-04-24
AR030284A1 (es) 2003-08-20
CN1182125C (zh) 2004-12-29
CZ20024013A3 (cs) 2003-03-12
CA2410404A1 (en) 2001-12-13
US6600040B2 (en) 2003-07-29
JP2003535852A (ja) 2003-12-02
HRP20020973A2 (en) 2005-02-28
IL152793A0 (en) 2003-06-24
BR0111472A (pt) 2004-01-06
US20020052494A1 (en) 2002-05-02
WO2001094324A1 (en) 2001-12-13
EA004743B1 (ru) 2004-08-26
KR20030007887A (ko) 2003-01-23
NZ523389A (en) 2004-08-27
MXPA02012101A (es) 2003-04-25
EP1292584A1 (en) 2003-03-19
HUP0400491A2 (hu) 2004-06-28

Similar Documents

Publication Publication Date Title
SK17082002A3 (sk) Spôsob prípravy (2R,2-alfa-R,3a)-2-[1-(3,5- bis(trifluórmetyl)fenyl)etoxy]-3-(4-fluórfenyl)-1,4-oxazínu
KR20070116286A (ko) 시나칼셋 염산염의 제조 방법
JP4503184B2 (ja) 2−アミノ−2−[2−(4−c2−20−アルキル−フェニル)エチル]プロパン−1,3−ジオール類の製造
US6469164B2 (en) Process for the synthesis of (2R, 2-alpha-R)-4-benzyl-2-[1-(3,5-bis (trifluoromethyl)phenyl)ethoxy]-1,4-oxazine-3-one
EA001377B1 (ru) Хиральные бифосфиновые соединения, комплексы на их основе и способ получения хирального бифосфинового соединения
US6395898B1 (en) Trans-glycosidation process for the synthesis of (2R, 2-alpha-R, 3a)-2-[1-(3,5-bis(trifluoromethyl)phenyl)ethoxy]-3-(4-fluorophenyl)-1,4-oxazine
JP3626763B2 (ja) 除草剤中間体o−ニトロフェニルシクロプロピルケトン及びo−アミノフェニルシクロプロピルケトンの製造法
EA005094B1 (ru) Способ получения циталопрама
US7223860B2 (en) Preparation of 2-(2-arylmorpholin-2-yl) ethanol derivatives and intermediates
US6538134B2 (en) 4-Benzyl-2-hydroxy-1,4-oxazine-3-one and polymorphic forms thereof
US6756502B2 (en) Intermediate and processes for its preparation and conversion into a pharmacologically-active agent
WO2001042232A1 (fr) Procede de production de tetrahydropyranyl-4-sulfonate et de 4-aminotetrahydropyrane
US6403793B2 (en) Intramolecular glycosidation process for the synthesis of (2R, 2-alpha-R, 3a)-2-[1-(3,5- bis (trifluoromethyl) phenyl)ethoxy]-3-(4-fluorophenyl)-1,4-oxazine
JP4032593B2 (ja) 4−アミノテトラヒドロピラン誘導体の製法
JP2003171354A (ja) 光学活性アミン化合物又はその塩の製造方法
JP2675924B2 (ja) アミノケトン類の製造方法
JPS6027668B2 (ja) 1−(4−イソプロピルチオフエニル)プロパン誘導体
EP0915699A4 (en) STEREPSELECTIVE SYNTHESIS OF ENDOTHELIN RECEPTOR ANTAGONISTS
JPS5811420B2 (ja) ベンゾビシクロアルカンアミン類の製法
JPH054393B2 (es)

Legal Events

Date Code Title Description
FC9A Refused patent application